Canine Oral Chewable Tablets Market: By Composition Type, By Drug Class, By Application, By Product Type ), By Distribution Channel and Region Forecast 2020-2031
Canine Oral Chewable Tablets Market size was valued at US$ 3.3 billion in 2024 and is expected to reach US$ 4.8 billion by 2031, growing at a significant CAGR of 5.42% from 2025-2031. The market is an oral dosage form of medication with additives used to treat various types of canine diseases such as arthritis, canine congestive heart failure, tick and flea infections, and among others. Various additives and flavoring agents are used in the formulation of canine oral chewable tablets to mask the unpleasant taste and odor of the drugs.
The canine oral chewable tablets will dissolve in 2-5 minutes and the pharmacological action takes place immediately. The global market is in the developing stage as several local and international players are actively engaged in the manufacturing of canine oral chewable tablets for the treatment of chronic canine diseases. Acquisitions and mergers, collaborations, joint ventures, and product launches, are some key strategies followed by the manufacturers for increasing their share in the global market.
Study Period
2025-2031Base Year
2024CAGR
X%Largest Market
Asia-PacificFastest Growing Market
North-America
Rise in the expenditure in animal welfare and wellness, wider availability of the canine oral chewable tablets in the market, and rise in the prevalence of various canine diseases such as tick and fleas infections, anticipated to fuel the global market over the forecast period. In addition, ease of administration of tablets compared with parenteral formulations, lack of nutrition values in the canine feed, and initiations taken by various pet organizations and NGOs for animal welfare are expected bolster the canine oral chewable tablets market over the forecast years.
However, stringent regulatory policies for the approval of veterinary formulations, lack of awareness about the canine oral chewable tablets in rural areas, high cost of the products, and withdrawn of drugs from the market such as levothyroxine sodium due to FDA warning regarding the lack of approval might hinder the global market growth in the coming future.
North America holds a significant share in global canine oral chewable tablets owing to increase in the adoption of canines (according to American Pet Products Association, approximately 78 Mn canines were owned in the U.S.), rise in the awareness of canines health, growth in the expenditure on animal welfare, increase in the research and development activities for the innovation of new products for chronic canine diseases might fuel the in the region.
Asia Pacific accounts for key share, which is attributed to increasing in the prevalence of various canine microbial diseases due to unhygienic conditions, a rise in the expenditure on animal welfare, and diversification of business segment in Asia Pacific region by various manufacturers might bolster the market in Asia Pacific region. Europe holds a major share owing to increase the awareness about pets health, a rise in the prevalence of various canine diseases, lack of nutrition fortified canine feed, and rise in research and development activities for the canine oral chewable tablets market might propel the market growth in Europe region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 3.3 billion |
|
Market Size in 2031 |
US$ 4.8 billion |
|
Market CAGR |
X% |
|
By Composition Type |
|
|
By Drugs Type |
|
|
By Application |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
The canine oral chewable tablets market size was valued at US$ 3.3 billion in 2024 and is expected to reach US$ 4.8 billion by 2031, growing at a significant CAGR of 5.42% from 2025-2031
The market key players are: Zoetis, Inc. (Pfizer) (U.S) Virbac AH Inc. (France) Elanco (Eli Lilly and Co.) (U.S.) Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany) Pala-Tech Laboratories (U.S.) Bayer HealthCare LLC, (Bayer AG) (Germany) Merck Animal Health (Merck &co. Inc.) (U.S.) Putney, Inc. (Dechra Pharmaceuticals) (U.K.)
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Canine Oral Chewable Tablets Market Introduction |
| 2.1.Global Canine Oral Chewable Tablets Market - Taxonomy |
| 2.2.Global Canine Oral Chewable Tablets Market - Definitions |
| 2.2.1.Composition Type |
| 2.2.2.Drugs Type |
| 2.2.3.Application |
| 2.2.4.Distribution Channel |
| 2.2.5.Region |
| 3. Global Canine Oral Chewable Tablets Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Canine Oral Chewable Tablets Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Canine Oral Chewable Tablets Market By Composition Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Botanically synthesized |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Chemically synthesized |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Global Canine Oral Chewable Tablets Market By Drugs Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Analgesics |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Anti-infective |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Anti-ulcers |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Vitamins & minerals |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Cardiovascular drugs |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Others |
| 6.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7. Global Canine Oral Chewable Tablets Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Gastrointestinal diseases |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Cardiovascular disorders |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Infectious diseases |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Nutritional supplements |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global Canine Oral Chewable Tablets Market By Distribution Channel, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. Veterinary clinics |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Veterinary Pharmacies |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Online veterinary stores |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Global Canine Oral Chewable Tablets Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Canine Oral Chewable Tablets Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Composition Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Botanically synthesized |
| 10.1.2.Chemically synthesized |
| 10.2. Drugs Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Analgesics |
| 10.2.2.Anti-infective |
| 10.2.3.Anti-ulcers |
| 10.2.4.Vitamins & minerals |
| 10.2.5.Cardiovascular drugs |
| 10.2.6.Others |
| 10.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Gastrointestinal diseases |
| 10.3.2.Cardiovascular disorders |
| 10.3.3.Infectious diseases |
| 10.3.4.Nutritional supplements |
| 10.3.5.Others |
| 10.4. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Veterinary clinics |
| 10.4.2.Veterinary Pharmacies |
| 10.4.3.Online veterinary stores |
| 10.4.4.Others |
| 10.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Canine Oral Chewable Tablets Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Composition Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Botanically synthesized |
| 11.1.2.Chemically synthesized |
| 11.2. Drugs Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Analgesics |
| 11.2.2.Anti-infective |
| 11.2.3.Anti-ulcers |
| 11.2.4.Vitamins & minerals |
| 11.2.5.Cardiovascular drugs |
| 11.2.6.Others |
| 11.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Gastrointestinal diseases |
| 11.3.2.Cardiovascular disorders |
| 11.3.3.Infectious diseases |
| 11.3.4.Nutritional supplements |
| 11.3.5.Others |
| 11.4. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Veterinary clinics |
| 11.4.2.Veterinary Pharmacies |
| 11.4.3.Online veterinary stores |
| 11.4.4.Others |
| 11.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Canine Oral Chewable Tablets Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Composition Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Botanically synthesized |
| 12.1.2.Chemically synthesized |
| 12.2. Drugs Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Analgesics |
| 12.2.2.Anti-infective |
| 12.2.3.Anti-ulcers |
| 12.2.4.Vitamins & minerals |
| 12.2.5.Cardiovascular drugs |
| 12.2.6.Others |
| 12.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Gastrointestinal diseases |
| 12.3.2.Cardiovascular disorders |
| 12.3.3.Infectious diseases |
| 12.3.4.Nutritional supplements |
| 12.3.5.Others |
| 12.4. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Veterinary clinics |
| 12.4.2.Veterinary Pharmacies |
| 12.4.3.Online veterinary stores |
| 12.4.4.Others |
| 12.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Canine Oral Chewable Tablets Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Composition Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Botanically synthesized |
| 13.1.2.Chemically synthesized |
| 13.2. Drugs Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Analgesics |
| 13.2.2.Anti-infective |
| 13.2.3.Anti-ulcers |
| 13.2.4.Vitamins & minerals |
| 13.2.5.Cardiovascular drugs |
| 13.2.6.Others |
| 13.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Gastrointestinal diseases |
| 13.3.2.Cardiovascular disorders |
| 13.3.3.Infectious diseases |
| 13.3.4.Nutritional supplements |
| 13.3.5.Others |
| 13.4. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Veterinary clinics |
| 13.4.2.Veterinary Pharmacies |
| 13.4.3.Online veterinary stores |
| 13.4.4.Others |
| 13.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Canine Oral Chewable Tablets Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 14.1. Composition Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Botanically synthesized |
| 14.1.2.Chemically synthesized |
| 14.2. Drugs Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Analgesics |
| 14.2.2.Anti-infective |
| 14.2.3.Anti-ulcers |
| 14.2.4.Vitamins & minerals |
| 14.2.5.Cardiovascular drugs |
| 14.2.6.Others |
| 14.3. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Gastrointestinal diseases |
| 14.3.2.Cardiovascular disorders |
| 14.3.3.Infectious diseases |
| 14.3.4.Nutritional supplements |
| 14.3.5.Others |
| 14.4. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Veterinary clinics |
| 14.4.2.Veterinary Pharmacies |
| 14.4.3.Online veterinary stores |
| 14.4.4.Others |
| 14.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Zoetis, Inc. (Pfizer) (U.S) |
| 15.2.2.Virbac AH Inc. (France) |
| 15.2.3.Elanco (Eli Lilly and Co.) (U.S.) |
| 15.2.4.Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany) |
| 15.2.5.Pala-Tech Laboratories (U.S.) |
| 15.2.6.Bayer HealthCare LLC, (Bayer AG) (Germany) |
| 15.2.7.Merck Animal Health (Merck &co. Inc.) (U.S.) |
| 15.2.8.Putney, Inc. (Dechra Pharmaceuticals) (U.K.) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
